Top compounds associated with response to RLN3


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CTRPv2 pan-cancer AAC -0.013 0.7
mRNA ATRA CTRPv2 pan-cancer AAC 0.015 0.7
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA VX-680 CTRPv2 pan-cancer AAC -0.044 0.7
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.015 0.7
mRNA AS605240 GDSC1000 pan-cancer AAC 0.014 0.7
Download CSV